Chinajoy Pharmaceutical (600479.SH) subsidiary obtains registration certificate for Sacubitril Valsartan Sodium Tablets.

Zhitong Finance APP News, Jiuzi Pharmaceutical (600479.SH) announced that recently, its subsidiary Hunan Qianjin Xielu Pharmaceutical Co., Ltd. (hereinafter referred to as "Qianjin Xielu Pharmaceutical") received the "Drug Registration Certificate" for Sacubitril Valsartan Sodium Tablets (200mg) approved and issued by the National Medical Products Administration (certificate number: 2025S01468).